Literature DB >> 15185103

Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis.

H Jürgen Wenzel1, Leena S Patel, Carol A Robbins, Adriana Emmi, Raymond S Yeung, Philip A Schwartzkroin.   

Abstract

Tuberous sclerosis (TSC) is an autosomal dominant disorder, caused by mutations of either the TSC1 or TSC2 gene. Characteristic brain pathologies (including cortical tubers and subependymal hamartomas/giant astrocytomas) are thought to cause epilepsy, as well as other neurological dysfunction. The Eker rat, which carries a spontaneous germline mutation of the TSC2 gene (TSC2+/-), provides a unique animal model in which to study the relationship between TSC cortical pathologies and epilepsy. In the present study, we have analyzed the seizure propensity and histopathological features of a modified Eker rat preparation, in which early postnatal irradiation was employed as a "second hit" stimulus in an attempt to exacerbate cortical malformations and increase seizure propensity. Irradiated Eker rats had a tendency toward lower seizure thresholds (latencies to flurothyl-induced seizures) than seen in non-irradiated Eker rats (significant difference) or irradiated wild-type rats (non-significant difference). The majority of irradiated Eker rats exhibited dysplastic cytomegalic neurons and giant astrocyte-like cells, similar to cytopathologies observed in TSC lesions of patients. The most prominent features in these brains were hamartoma-like lesions involving large eosinophilic cells, similar to giant tuber cells in human TSC. In some cells from these hamartomas, immunocytochemistry revealed features of both neuronal and glial phenotypes, suggesting an undifferentiated or immature cell population. Both normal-appearing and dysmorphic neurons, as well as cells in the hamartomas, exhibited immunopositivity for tuberin, the protein product of the TSC2 gene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15185103     DOI: 10.1007/s00401-004-0865-8

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  25 in total

1.  Progress toward understanding epileptogenesis in tuberous sclerosis complex: two hits, no outs, and the Eker rat is up to bat.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2005 Jul-Aug       Impact factor: 7.500

2.  Is cognition altered in the eker rat model of tuberous sclerosis complex?

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2006 Nov-Dec       Impact factor: 7.500

Review 3.  Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges.

Authors:  Romina Moavero; Caterina Cerminara; Paolo Curatolo
Journal:  Childs Nerv Syst       Date:  2010-04-01       Impact factor: 1.475

Review 4.  New frontiers in modeling tuberous sclerosis with human stem cell-derived neurons and brain organoids.

Authors:  John D Blair; Helen S Bateup
Journal:  Dev Dyn       Date:  2019-05-23       Impact factor: 3.780

5.  Irradiation exacerbates cortical cytopathology in the Eker rat model of tuberous sclerosis complex, but does not induce hyperexcitability.

Authors:  Naranzogt Tschuluun; H Jürgen Wenzel; Philip A Schwartzkroin
Journal:  Epilepsy Res       Date:  2006-09-29       Impact factor: 3.045

Review 6.  The neurobiology of the tuberous sclerosis complex.

Authors:  Leah Marcotte; Peter B Crino
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 7.  The tuberous sclerosis complex.

Authors:  Ksenia A Orlova; Peter B Crino
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

8.  Ubiquitin-positive intranuclear inclusions in neuronal and glial cells in a mouse model of the fragile X premutation.

Authors:  H Jürgen Wenzel; Michael R Hunsaker; Claudia M Greco; Rob Willemsen; Robert F Berman
Journal:  Brain Res       Date:  2010-01-04       Impact factor: 3.252

9.  The natural history and treatment of epilepsy in a murine model of tuberous sclerosis.

Authors:  Ebru Erbayat-Altay; Ling-Hui Zeng; Lin Xu; David H Gutmann; Michael Wong
Journal:  Epilepsia       Date:  2007-05-01       Impact factor: 5.864

10.  Animal models of focal cortical dysplasia and tuberous sclerosis complex: recent progress toward clinical applications.

Authors:  Michael Wong
Journal:  Epilepsia       Date:  2009-10       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.